Clinical Trials Insight: 700014150
Phase of Trial: Phase II
Latest Information Update: 10 Feb 2010
At a glance
- Drugs Ragweed allergy immunotherapy (Primary)
- Indications Allergic asthma; Rhinoconjunctivitis; Seasonal allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Greer Laboratories
- 10 Feb 2010 Results have been published early online in the Journal of Allergy and Clinical Immunology.
- 15 Mar 2008 Status changed from recruiting to completed.
- 31 Jul 2006 New trial record.